| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |